CITADEL ADVISORS LLC historic quarter change: USA Warrants, Reduced
In warrants (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 1,717 positions, added to 870, reduced 1,219 and sold out of 1,694.
- Q3 2025: Stock BONE BIOLOGICS CORP; Country of operation —; Class *W EXP 10/13/202; Shares before 35,673.
- Q3 2025: Stock LOCAFY LIMITED; Country of operation —; Class *W EXP 03/29/202; Shares before 44,645.
- Q3 2025: Stock HEARTSCIENCES INC; Country of operation —; Class *W EXP 06/15/202; Shares before 223,519.
- Q3 2025: Stock BIOAFFINITY TECHNOLOGIES INC; Country of operation —; Class *W EXP 09/07/202; Shares before 32,355.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2025 | BONE BIOLOGICS CORP
CUSIP 098070154 | — | *W EXP 10/13/202 | 35,673 | 35,573 | -100 | $535,095 | $355,730 | -$179,365 | 2025-11-14 |
|---|
| Q3 2025 | LOCAFY LIMITED
CUSIP Q56120142 | — | *W EXP 03/29/202 | 44,645 | 44,503 | -142 | $486,631 | $458,381 | -$28,250 | 2025-11-14 |
|---|
| Q3 2025 | HEARTSCIENCES INC
CUSIP 42254E112 | — | *W EXP 06/15/202 | 223,519 | 214,098 | -9,421 | $20,430 | $29,760 | +$9,330 | 2025-11-14 |
|---|
| Q3 2025 | BIOAFFINITY TECHNOLOGIES INC
CUSIP 09076W117 | — | *W EXP 09/07/202 | 32,355 | 30,584 | -1,771 | $4,206 | $13,151 | +$8,945 | 2025-11-14 |
|---|
| Q3 2025 | NUTRIBAND INC
CUSIP 67092M125 | — | *W EXP 99/99/999 | 146,834 | 134,995 | -11,839 | $234,934 | $229,492 | -$5,442 | 2025-11-14 |
|---|
| Q3 2025 | APOLLOMICS INC
CUSIP G0411D115 | — | *W EXP 04/01/202 | 158,131 | 105,642 | -52,489 | $7,021 | $2,007 | -$5,014 | 2025-11-14 |
|---|
| Q3 2025 | NUVATION BIO INC
CUSIP 67080N119 | — | *W EXP 02/10/202 | 73,545 | 73,420 | -125 | $19,850 | $14,839 | -$5,011 | 2025-11-14 |
|---|
| Q3 2025 | ABLE VIEW GLOBAL INC
CUSIP G1149B116 | — | *W EXP 08/18/202 | 252,334 | 251,440 | -894 | $4,189 | $8,448 | +$4,259 | 2025-11-14 |
|---|
| Q3 2025 | SUNSHINE BIOPHARMA INC
CUSIP 867781502 | — | *W EXP 99/99/999 | 20,415 | 12,073 | -8,342 | $5,308 | $1,660 | -$3,648 | 2025-11-14 |
|---|
| Q3 2025 | BENEFICIENT
CUSIP 08178Q119 | United States | *W EXP 06/07/202 | 605,336 | 15,650 | -589,686 | $3,269 | $227 | -$3,042 | 2025-11-14 |
|---|
| Q3 2025 | ROCKET PHARMACEUTICALS INC
CUSIP 77313F114 | — | *W EXP 09/02/202 | 314,842 | 312,789 | -2,053 | $9,067 | $11,260 | +$2,193 | 2025-11-14 |
|---|
| Q3 2025 | AMPLITECH GROUP INC
CUSIP 03211Q119 | — | *W EXP 02/26/202 | 22,816 | 21,603 | -1,213 | $10,267 | $8,777 | -$1,490 | 2025-11-14 |
|---|
| Q3 2025 | ECD AUTOMOTIVE DESIGN INC
CUSIP 27877D112 | — | *W EXP 12/12/202 | 216,906 | 202,720 | -14,186 | $5,184 | $4,054 | -$1,130 | 2025-11-14 |
|---|
| Q3 2025 | NEXTPLAT CORP
CUSIP 68557F118 | — | *W EXP 06/02/202 | 13,272 | 12,966 | -306 | $1,593 | $528 | -$1,065 | 2025-11-14 |
|---|
| Q3 2025 | VERSUS SYSTEMS INC
CUSIP 92540Q114 | — | *W EXP 11/22/202 | 43,186 | 39,545 | -3,641 | $1,727 | $2,578 | +$851 | 2025-11-14 |
|---|
| Q3 2025 | TENON MEDICAL INC
CUSIP 88066N113 | — | *W EXP 06/16/202 | 84,904 | 72,330 | -12,574 | $1,367 | $723 | -$644 | 2025-11-14 |
|---|
| Q3 2025 | CAPTIVISION INC
CUSIP G18932114 | — | *W EXP 11/15/202 | 35,306 | 33,606 | -1,700 | $847 | $1,344 | +$497 | 2025-11-14 |
|---|
| Q3 2025 | SWVL HOLDINGS CORP
CUSIP G86302117 | — | *W EXP 99/99/999 | 59,416 | 20,476 | -38,940 | $743 | $297 | -$446 | 2025-11-14 |
|---|
| Q3 2025 | BANZAI INTERNATIONAL INC
CUSIP 06682J118 | — | *W EXP 12/14/202 | 211,189 | 191,306 | -19,883 | $4,688 | $5,108 | +$420 | 2025-11-14 |
|---|
| Q3 2025 | PYXIS TANKERS INC
CUSIP Y71726122 | — | *W EXP 10/13/202 | 20,241 | 19,796 | -445 | $607 | $194 | -$413 | 2025-11-14 |
|---|
| Q3 2025 | EON RESOURCES INC
CUSIP 40472A128 | — | *W EXP 02/04/202 | 134,622 | 129,721 | -4,901 | $6,879 | $6,486 | -$393 | 2025-11-14 |
|---|
| Q3 2025 | CHECHE GROUP INC
CUSIP G20707116 | — | *W EXP 10/01/203 | 26,855 | 23,267 | -3,588 | $679 | $996 | +$317 | 2025-11-14 |
|---|
| Q3 2025 | AMERICAN REBEL HLDGS INC
CUSIP 02919L117 | — | *W EXP 01/20/202 | 23,973 | 23,645 | -328 | $827 | $544 | -$283 | 2025-11-14 |
|---|
| Q3 2025 | BOLT PROJS HLDGS INC
CUSIP 09769B115 | — | *W EXP 08/13/202 | 47,667 | 31,277 | -16,390 | $1,030 | $1,311 | +$281 | 2025-11-14 |
|---|
| Q3 2025 | MSP RECOVERY INC
CUSIP 553745118 | — | *W EXP 05/23/202 | 45,375 | 42,575 | -2,800 | $908 | $643 | -$265 | 2025-11-14 |
|---|
| Q3 2025 | NEWGENIVF GROUP LIMITED
CUSIP G0544E113 | — | *W EXP 04/03/202 | 29,776 | 29,609 | -167 | $694 | $489 | -$205 | 2025-11-14 |
|---|
| Q3 2025 | GENERATION INCOME PPTYS INC
CUSIP 37149D113 | — | *W EXP 99/99/999 | 25,683 | 25,387 | -296 | $1,418 | $1,269 | -$149 | 2025-11-14 |
|---|
| Q3 2025 | PASITHEA THERAPEUTICS CORP
CUSIP 70261F111 | — | *W EXP 08/12/202 | 15,511 | 15,191 | -320 | $335 | $207 | -$128 | 2025-11-14 |
|---|
| Q3 2025 | REVELATION BIOSCIENCES INC
CUSIP 76135L119 | — | *W EXP 01/10/202 | 36,048 | 31,798 | -4,250 | $433 | $321 | -$112 | 2025-11-14 |
|---|
| Q3 2025 | AUDDIA INC
CUSIP 05072K115 | — | *W EXP 02/19/202 | 74,961 | 72,697 | -2,264 | $1,732 | $1,636 | -$96 | 2025-11-14 |
|---|
| Q3 2025 | XOS INC
CUSIP 98423B116 | — | *W EXP 08/20/202 | 25,813 | 15,855 | -9,958 | $245 | $165 | -$80 | 2025-11-14 |
|---|
| Q3 2025 | RELIANCE GLOBAL GROUP INC
CUSIP 75946W116 | — | *W EXP 02/01/202 | 40,453 | 33,055 | -7,398 | $1,331 | $1,405 | +$74 | 2025-11-14 |
|---|
| Q3 2025 | JEFFS BRANDS LTD
CUSIP M61472110 | — | *W EXP 99/99/999 | 28,293 | 28,093 | -200 | $772 | $840 | +$68 | 2025-11-14 |
|---|
| Q3 2025 | MKDWELL TECH INC
CUSIP G6209W116 | — | *W EXP 07/31/202 | 37,677 | 35,853 | -1,824 | $441 | $394 | -$47 | 2025-11-14 |
|---|
| Q3 2025 | MOOLEC SCIENCE SA
CUSIP L64875112 | — | *W EXP 12/30/202 | 53,097 | 52,497 | -600 | $796 | $766 | -$30 | 2025-11-14 |
|---|
| Q3 2025 | SHF HOLDINGS INC
CUSIP 824430110 | — | *W EXP 09/28/202 | 22,390 | 15,368 | -7,022 | $490 | $519 | +$29 | 2025-11-14 |
|---|
| Q3 2025 | MULTISENSOR AI HOLDINGS INC
CUSIP 456948116 | — | *W EXP 12/19/202 | 19,892 | 16,192 | -3,700 | $607 | $615 | +$8 | 2025-11-14 |
|---|
| Q3 2025 | XBP GLOBAL HOLDINGS INC
CUSIP 98400V119 | — | *W EXP 11/30/202 | 12,066 | 10,065 | -2,001 | $410 | $403 | -$7 | 2025-11-14 |
|---|
| Q3 2025 | SONDER HOLDINGS INC
CUSIP 83542D110 | — | *W EXP 01/18/202 | 13,853 | 13,043 | -810 | $130 | $137 | +$7 | 2025-11-14 |
|---|